Marchex Toekomstige groei
Future criteriumcontroles 0/6
Marchex's earnings are forecast to decline at 7.6% per annum while its annual revenue is expected to grow at 4.7% per year. EPS is expected to decline by 5.4% per annum.
Belangrijke informatie
-7.6%
Groei van de winst
-5.4%
Groei van de winst per aandeel
Media winstgroei | 13.1% |
Inkomstengroei | 4.7% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 01 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Marchex, Inc. (NASDAQ:MCHX) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected
Aug 05Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?
Mar 01Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?
Oct 19What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash
Sep 14Companies Like Marchex (NASDAQ:MCHX) Are In A Position To Invest In Growth
May 11We're Not Very Worried About Marchex's (NASDAQ:MCHX) Cash Burn Rate
Jan 05We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely
Sep 15We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely
Apr 17Marchex: Hope Springs Eternal
Sep 29Does Marchex (NASDAQ:MCHX) Have A Healthy Balance Sheet?
Aug 08Is Marchex (NASDAQ:MCHX) Using Debt Sensibly?
Apr 16How Much Of Marchex, Inc. (NASDAQ:MCHX) Do Insiders Own?
Mar 12A Look At Marchex's (NASDAQ:MCHX) Share Price Returns
Feb 05Marchex Inc.: Cheap Company Expected To Grow In 2021
Jan 07Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 54 | -5 | N/A | N/A | 1 |
12/31/2025 | 50 | -5 | N/A | N/A | 2 |
12/31/2024 | 48 | -5 | N/A | N/A | 2 |
9/30/2024 | 49 | -4 | N/A | N/A | N/A |
6/30/2024 | 49 | -5 | -2 | -1 | N/A |
3/31/2024 | 49 | -7 | -3 | -2 | N/A |
12/31/2023 | 50 | -10 | -6 | -4 | N/A |
9/30/2023 | 50 | -12 | -8 | -7 | N/A |
6/30/2023 | 50 | -12 | -9 | -7 | N/A |
3/31/2023 | 51 | -11 | -7 | -5 | N/A |
12/31/2022 | 52 | -8 | -5 | -2 | N/A |
9/30/2022 | 53 | -7 | -5 | -2 | N/A |
6/30/2022 | 53 | -2 | -4 | -1 | N/A |
3/31/2022 | 54 | -1 | -5 | -2 | N/A |
12/31/2021 | 53 | -4 | -8 | -6 | N/A |
9/30/2021 | 53 | -8 | -8 | -7 | N/A |
6/30/2021 | 53 | -16 | -10 | -9 | N/A |
3/31/2021 | 52 | -22 | -8 | -7 | N/A |
12/31/2020 | 51 | -42 | -5 | -3 | N/A |
9/30/2020 | 15 | -42 | -5 | -4 | N/A |
6/30/2020 | 26 | -39 | -2 | 0 | N/A |
3/31/2020 | 40 | -34 | -4 | -2 | N/A |
12/31/2019 | 54 | -10 | 3 | 5 | N/A |
9/30/2019 | 101 | -4 | 6 | 8 | N/A |
6/30/2019 | 96 | -4 | 7 | 8 | N/A |
3/31/2019 | 90 | -3 | 6 | 8 | N/A |
12/31/2018 | 85 | -3 | 3 | 5 | N/A |
9/30/2018 | 84 | -3 | 2 | 4 | N/A |
6/30/2018 | 86 | -3 | N/A | 4 | N/A |
3/31/2018 | 88 | -4 | N/A | 6 | N/A |
12/31/2017 | 90 | -6 | N/A | 2 | N/A |
9/30/2017 | 97 | -11 | N/A | 1 | N/A |
6/30/2017 | 106 | -16 | N/A | -2 | N/A |
3/31/2017 | 118 | -84 | N/A | -2 | N/A |
12/31/2016 | 130 | -84 | N/A | -4 | N/A |
9/30/2016 | 136 | -77 | N/A | -2 | N/A |
6/30/2016 | 142 | -71 | N/A | 6 | N/A |
3/31/2016 | 143 | -4 | N/A | 4 | N/A |
12/31/2015 | 143 | -1 | N/A | 13 | N/A |
9/30/2015 | 139 | -2 | N/A | 16 | N/A |
6/30/2015 | 150 | -24 | N/A | 15 | N/A |
3/31/2015 | 161 | -23 | N/A | 21 | N/A |
12/31/2014 | 174 | -23 | N/A | 22 | N/A |
9/30/2014 | 182 | -22 | N/A | 24 | N/A |
6/30/2014 | 175 | 1 | N/A | 22 | N/A |
3/31/2014 | 166 | 1 | N/A | 20 | N/A |
12/31/2013 | 148 | -2 | N/A | 14 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: MCHX is forecast to remain unprofitable over the next 3 years.
Winst versus markt: MCHX is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: MCHX is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: MCHX's revenue (4.7% per year) is forecast to grow slower than the US market (8.9% per year).
Hoge groei-inkomsten: MCHX's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if MCHX's Return on Equity is forecast to be high in 3 years time